Mr Radatz Chairs Expert Discussion On Metastases At BRSS
On 24 January, Mr Matthias Radatz will be chairing a panel discussion at the BRSS titled: “What’s the Limit to the Number of Metastases That We Can Treat?”
On 24 January, Mr Matthias Radatz will be chairing a panel discussion at the BRSS titled: “What’s the Limit to the Number of Metastases That We Can Treat?”
We are delighted that members of our medical team have presented at the 9th Annual Meeting of the British Radiosurgery Society (BRSS), which took place in Birmingham on January 23-24. Amethyst Radiotherapy also provided sponsorship for the event.
On Friday 24 January, Mr Matthias Radatz chaired a panel discussion titled: “What’s the Limit to the Number of Metastases That We Can Treat?”
Amethyst Radiotherapy is one of the very few healthcare providers in the UK that specialises in the use of Gamma Knife technology to treat certain types of neurological disorders and brain tumours, working alongside NHS Trusts and with private patients.
Where brain metastases are concerned, one of the biggest challenges is how treatment can be delivered effectively across the blood-brain barrier, as well as the number and size of metastases, the potential for radiation-related cognitive impairment, the individual’s general health and how aggressive the primary cancer is.
Current treatment options for brain tumours include surgery, stereotactic radiosurgery, whole-brain radiation therapy and Gamma Knife surgery, which is what Amethyst Radiotherapy specialises in.
Gamma Knife is a form of stereotactic radiosurgery. It is not the type of surgery that involves making incisions with a knife, but is a form of radiation therapy delivered from an external machine. It makes use of highly focused beams of gamma radiation that are directed from multiple angles to safely deliver a high dose of radiation to the affected area.
It is mainly used to treat malignant and benign brain tumours, trigeminal neuralgia, and acoustic neuromas.
The patient is fitted with a head frame to ensure that the treatment area is still during the radiation delivery. The exact location and size of the tumour (or other disorder) is accurately pinpointed with a CT or MRI scan, and the medical team uses this information to calculate the radiation beam positioning and dose.
In most cases, the treatment is delivered in a single session, which causes minimal discomfort and has a low risk of side effects. The patient will usually be able to resume normal activities within a day or two. The treatment is regarded as effective, and avoids the need for much riskier traditional neurosurgery.
Centres of Excellence for Stereotactic Radiosurgery treatment of complex Brain Tumours
Want to know more about Gamma Knife Treatment?
Our friendly staff are here to help you, get in touch with them today